Comments
Loading...

Galera Therapeutics (GRTX) Stock Price, Quote, News & History

GRTXOTCQB
Logo brought to you by Benzinga Data
Price data is not available

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-6.79M
Investing Cash Flow (TTM)
-50.00K
Financing Cash Flow (TTM)
2.86M
Free Cash Flow (TTM)
-6.79M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-3.98M

Analyst Rating and Forecast

12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$2.08M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-454.55%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$1.98

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$4.47M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 120.46K
Day Range
- - -
52 Wk Range
0.02 - 0.05
Market Cap
$1.66M
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Galera Therapeutics Inc is a biopharmaceutical company that has been developing a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer, by reducing one of the most common side effects of radiotherapy, severe oral muc...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GRTX

FAQ

Q

How do I buy Galera Therapeutics (GRTX) stock?

A

You can purchase shares of Galera Therapeutics (OTCQB:GRTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Galera Therapeutics (GRTX) competitors?

A

There are no as such competitors for Galera Therapeutics.

Q

What is the forecast, or price target, for Galera Therapeutics (GRTX) stock?

A

Galera Therapeutics has a consensus price target of $2.01.

Q

What is the current price for Galera Therapeutics (GRTX)?

A

The stock price for Galera Therapeutics (OTCQB: GRTX) is $ last updated .

Q

Does Galera Therapeutics (GRTX) pay a dividend?

A

There are no upcoming dividends for Galera Therapeutics.

Q

When is Galera Therapeutics (OTCQB:GRTX) reporting earnings?

A

Galera Therapeutics does not have any upcoming earnings scheduled.

Q

Is Galera Therapeutics (GRTX) going to split?

A

There is no upcoming split for Galera Therapeutics.

Q

What sector and industry does Galera Therapeutics (GRTX) operate in?

A

Galera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.